Duodenal intraepithelial lymphocytosis with normal villous architecture: common occurrence in H. pylori gastritis.

PubWeight™: 1.08‹?› | Rank: Top 10%

🔗 View Article (PMID 15803187)

Published in Mod Pathol on August 01, 2005

Authors

Lorenzo Memeo1, Jeffrey Jhang, Hanina Hibshoosh, Peter H Green, Heidrun Rotterdam, Govind Bhagat

Author Affiliations

1: Department of Pathology, College of Physicians and Surgeons, Columbia University Medical Center, New York, NY 10032, USA.

Articles citing this

Decreased risk of celiac disease in patients with Helicobacter pylori colonization. Am J Epidemiol (2013) 2.58

Detection of celiac disease and lymphocytic enteropathy by parallel serology and histopathology in a population-based study. Gastroenterology (2010) 2.01

A Prospective Study on the Usefulness of Duodenal Bulb Biopsies in Celiac Disease Diagnosis in Children: Urging Caution. Am J Gastroenterol (2016) 1.08

Consequences of Helicobacter pylori infection in children. World J Gastroenterol (2010) 1.03

PPAR signaling pathway and cancer-related proteins are involved in celiac disease-associated tissue damage. Mol Med (2010) 0.94

Clinical and histological presentation of Helicobacter pylori and gluten related gastroenteropathy. Arch Iran Med (2011) 0.90

Paediatric T-cell lymphoma of the appendix: a case report. Diagn Pathol (2013) 0.90

H.pylori associated with iron deficiency anemia even in celiac disease patients; strongly evidence based but weakly reflected in practice. Gastroenterol Hepatol Bed Bench (2015) 0.87

Duodenal intraepithelial T lymphocytes in patients with functional dyspepsia. World J Gastroenterol (2007) 0.85

The management of refractory coeliac disease. Ther Adv Chronic Dis (2013) 0.83

Intraepithelial lymphocyte distribution differs between the bulb and the second part of duodenum. BMC Gastroenterol (2013) 0.77

Relationship between Helicobacter pylori infection and celiac disease: a cross-sectional study and a brief review of the literature. Prz Gastroenterol (2017) 0.75

Pathological and Clinical Correlation between Celiac Disease and Helicobacter Pylori Infection; a Review of Controversial Reports. Middle East J Dig Dis (2016) 0.75

Intraepithelial lymphocytes, scores, mimickers and challenges in diagnosing gluten-sensitive enteropathy (celiac disease). World J Gastroenterol (2017) 0.75

Histomorphological Spectrum of Duodenal Pathology in Functional Dyspepsia Patients. J Clin Diagn Res (2017) 0.75

[Histological diagnosis and complications of celiac disease. Update according to the new S2k guidelines]. Pathologe (2015) 0.75

Time trend occurrence of duodenal intraepithelial lymphocytosis and celiac disease in an open access endoscopic population. United European Gastroenterol J (2016) 0.75

Articles by these authors

Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene. J Clin Invest (2003) 16.67

PIK3CA mutations correlate with hormone receptors, node metastasis, and ERBB2, and are mutually exclusive with PTEN loss in human breast carcinoma. Cancer Res (2005) 8.98

Mutations of multiple genes cause deregulation of NF-kappaB in diffuse large B-cell lymphoma. Nature (2009) 7.37

Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia. Nat Med (2007) 6.55

Analysis of the coding genome of diffuse large B-cell lymphoma. Nat Genet (2011) 6.06

Poor prognosis in carcinoma is associated with a gene expression signature of aberrant PTEN tumor suppressor pathway activity. Proc Natl Acad Sci U S A (2007) 5.44

The DLEU2/miR-15a/16-1 cluster controls B cell proliferation and its deletion leads to chronic lymphocytic leukemia. Cancer Cell (2010) 4.71

Overexpression of interleukin-1beta induces gastric inflammation and cancer and mobilizes myeloid-derived suppressor cells in mice. Cancer Cell (2008) 4.43

Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease. Immunity (2004) 4.36

Recurrent gross mutations of the PTEN tumor suppressor gene in breast cancers with deficient DSB repair. Nat Genet (2007) 3.95

A signaling pathway mediating downregulation of BCL6 in germinal center B cells is blocked by BCL6 gene alterations in B cell lymphoma. Cancer Cell (2007) 3.81

Akt-mediated regulation of autophagy and tumorigenesis through Beclin 1 phosphorylation. Science (2012) 3.24

Educating medical students in laboratory medicine: a proposed curriculum. Am J Clin Pathol (2010) 3.18

Villous atrophy and negative celiac serology: a diagnostic and therapeutic dilemma. Am J Gastroenterol (2013) 3.13

Duodenal histology in patients with celiac disease after treatment with a gluten-free diet. Gastrointest Endosc (2003) 3.11

Population attributable risks of esophageal and gastric cancers. J Natl Cancer Inst (2003) 3.07

Breast implant-associated anaplastic large-cell lymphoma: long-term follow-up of 60 patients. J Clin Oncol (2013) 3.04

Nomenclature of the finer branches of the biliary tree: canals, ductules, and ductular reactions in human livers. Hepatology (2004) 3.00

Lack of PTEN sequesters CHK1 and initiates genetic instability. Cancer Cell (2005) 2.98

A secreted PTEN phosphatase that enters cells to alter signaling and survival. Science (2013) 2.86

AID is required for germinal center-derived lymphomagenesis. Nat Genet (2007) 2.79

IRF-4-binding protein inhibits interleukin-17 and interleukin-21 production by controlling the activity of IRF-4 transcription factor. Immunity (2008) 2.78

BLIMP1 is a tumor suppressor gene frequently disrupted in activated B cell-like diffuse large B cell lymphoma. Cancer Cell (2010) 2.73

microRNA-29a induces aberrant self-renewal capacity in hematopoietic progenitors, biased myeloid development, and acute myeloid leukemia. J Exp Med (2010) 2.68

Early-stage epigenetic modification during somatic cell reprogramming by Parp1 and Tet2. Nature (2012) 2.64

EGFR-mediated Beclin 1 phosphorylation in autophagy suppression, tumor progression, and tumor chemoresistance. Cell (2013) 2.63

Activation of the PI3K pathway in cancer through inhibition of PTEN by exchange factor P-REX2a. Science (2009) 2.51

The NF-{kappa}B negative regulator TNFAIP3 (A20) is inactivated by somatic mutations and genomic deletions in marginal zone lymphomas. Blood (2009) 2.36

MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program. Blood (2013) 2.30

Histamine deficiency promotes inflammation-associated carcinogenesis through reduced myeloid maturation and accumulation of CD11b+Ly6G+ immature myeloid cells. Nat Med (2010) 2.30

Chromatin and sequence features that define the fine and gross structure of genomic methylation patterns. Genome Res (2010) 2.25

Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP Consortium Program Study. Blood (2012) 2.16

Bile acid and inflammation activate gastric cardia stem cells in a mouse model of Barrett-like metaplasia. Cancer Cell (2012) 2.16

BAF180 is a critical regulator of p21 induction and a tumor suppressor mutated in breast cancer. Cancer Res (2008) 2.06

Reprogramming of CTLs into natural killer-like cells in celiac disease. J Exp Med (2006) 2.03

Combined genetic inactivation of β2-Microglobulin and CD58 reveals frequent escape from immune recognition in diffuse large B cell lymphoma. Cancer Cell (2011) 2.01

Bibliometric study of the quality of celiac disease research publications. J Pediatr Gastroenterol Nutr (2013) 1.98

Transfusion of human volunteers with older, stored red blood cells produces extravascular hemolysis and circulating non-transferrin-bound iron. Blood (2011) 1.92

Pancreatic cancer screening in a prospective cohort of high-risk patients: a comprehensive strategy of imaging and genetics. Clin Cancer Res (2010) 1.92

Risk of malignancy in patients with celiac disease. Am J Med (2003) 1.85

Prospective study of the role of duodenal bulb biopsies in the diagnosis of celiac disease. Gastrointest Endosc (2010) 1.79

Functional dissection of the chromosome 13q14 tumor-suppressor locus using transgenic mouse lines. Blood (2011) 1.72

CD30 expression defines a novel subgroup of diffuse large B-cell lymphoma with favorable prognosis and distinct gene expression signature: a report from the International DLBCL Rituximab-CHOP Consortium Program Study. Blood (2013) 1.72

Whole-genome sequencing identifies recurrent somatic NOTCH2 mutations in splenic marginal zone lymphoma. J Exp Med (2012) 1.66

EUS-guided trucut needle biopsies in patients with solid pancreatic masses: a prospective study. Gastrointest Endosc (2004) 1.64

BCL6 suppression of BCL2 via Miz1 and its disruption in diffuse large B cell lymphoma. Proc Natl Acad Sci U S A (2009) 1.62

Reduced expression of PTEN correlates with breast cancer progression. Hum Pathol (2002) 1.53

Dendritic cell (DC)-specific targeting reveals Stat3 as a negative regulator of DC function. J Immunol (2010) 1.53

Prior endoscopy in patients with newly diagnosed celiac disease: a missed opportunity? Dig Dis Sci (2013) 1.53

Single nucleotide variation in the TP53 3' untranslated region in diffuse large B-cell lymphoma treated with rituximab-CHOP: a report from the International DLBCL Rituximab-CHOP Consortium Program. Blood (2013) 1.52

Hematogones are markedly reduced in pediatric acquired aplastic anemia: multiparametric flow cytometric analysis. Leuk Lymphoma (2009) 1.51

FISH analysis in addition to G-band karyotyping: utility in evaluation of myelodysplastic syndromes? Leuk Res (2009) 1.50

Quantitative estimates of motility from videocapsule endoscopy are useful to discern celiac patients from controls. Dig Dis Sci (2012) 1.47

The BH3-only mimetic ABT-737 synergizes the antineoplastic activity of proteasome inhibitors in lymphoid malignancies. Blood (2008) 1.45

EUS followed by EMR for staging of high-grade dysplasia and early cancer in Barrett's esophagus. Gastrointest Endosc (2005) 1.45

Igf1r as a therapeutic target in a mouse model of basal-like breast cancer. Proc Natl Acad Sci U S A (2009) 1.45

3-Phosphoinositide-dependent kinase 1 potentiates upstream lesions on the phosphatidylinositol 3-kinase pathway in breast carcinoma. Cancer Res (2009) 1.43

BRCA2 mutation-associated breast cancers exhibit a distinguishing phenotype based on morphology and molecular profiles from tissue microarrays. Am J Surg Pathol (2007) 1.43

Transient celiac autoimmunity in an adult. J Clin Gastroenterol (2011) 1.43

Phosphorylation of IRF4 by ROCK2 regulates IL-17 and IL-21 production and the development of autoimmunity in mice. J Clin Invest (2010) 1.40

Seronegative celiac disease: increased prevalence with lesser degrees of villous atrophy. Dig Dis Sci (2004) 1.39

Targeted genomic sequencing of pediatric Burkitt lymphoma identifies recurrent alterations in antiapoptotic and chromatin-remodeling genes. Blood (2012) 1.38

TGFBI deficiency predisposes mice to spontaneous tumor development. Cancer Res (2009) 1.34

Interobserver agreement and reproducibility in classification of invasive breast carcinoma: an NCI breast cancer family registry study. Mod Pathol (2006) 1.31

Prevalence of gluten-free diet adherence among individuals without celiac disease in the USA: results from the Continuous National Health and Nutrition Examination Survey 2009-2010. Scand J Gastroenterol (2013) 1.31

Genome-wide DNA profiling of marginal zone lymphomas identifies subtype-specific lesions with an impact on the clinical outcome. Blood (2010) 1.27

IFN-γ inhibits gastric carcinogenesis by inducing epithelial cell autophagy and T-cell apoptosis. Cancer Res (2011) 1.26

Budesonide in the treatment of refractory celiac disease. Am J Gastroenterol (2007) 1.23

An association between microscopic colitis and celiac disease. Clin Gastroenterol Hepatol (2009) 1.23

Prognostic significance of gene-specific promoter hypermethylation in breast cancer patients. Breast Cancer Res Treat (2011) 1.22

HDAC inhibitors and decitabine are highly synergistic and associated with unique gene-expression and epigenetic profiles in models of DLBCL. Blood (2011) 1.22

Patients with diffuse large B-cell lymphoma of germinal center origin with BCL2 translocations have poor outcome, irrespective of MYC status: a report from an International DLBCL rituximab-CHOP Consortium Program Study. Haematologica (2012) 1.21

CD24 is a new oncogene, early at the multistep process of colorectal cancer carcinogenesis. Gastroenterology (2006) 1.20

Overexpression of interleukin-1beta in the murine pancreas results in chronic pancreatitis. Gastroenterology (2008) 1.18

Inflammatory bowel disease in patients with celiac disease. Inflamm Bowel Dis (2005) 1.17

Food group intake and risk of subtypes of esophageal and gastric cancer. Int J Cancer (2008) 1.17

Distinguishing patients with celiac disease by quantitative analysis of videocapsule endoscopy images. Comput Methods Programs Biomed (2010) 1.17

Variability in small bowel histopathology reporting between different pathology practice settings: impact on the diagnosis of coeliac disease. J Clin Pathol (2011) 1.14

Prevalence and clinical implications of epstein-barr virus infection in de novo diffuse large B-cell lymphoma in Western countries. Clin Cancer Res (2014) 1.13

Prevalence and clinical implications of cyclin D1 expression in diffuse large B-cell lymphoma (DLBCL) treated with immunochemotherapy: a report from the International DLBCL Rituximab-CHOP Consortium Program. Cancer (2014) 1.13

IRF4 and its regulators: evolving insights into the pathogenesis of inflammatory arthritis? Immunol Rev (2010) 1.12

Extraintestinal manifestations of celiac disease. Curr Gastroenterol Rep (2006) 1.10

Lymphoid follicle colonization by Bcl-2(bright+)CD10(+) B-cells ("follicular lymphoma in situ") at nodal and extranodal sites can be a manifestation of follicular homing of lymphoma. Hum Pathol (2013) 1.09

Aggressive presentation of breast implant-associated ALK-1 negative anaplastic large cell lymphoma with bilateral axillary lymph node involvement. Leuk Lymphoma (2009) 1.09

The pattern of cytoplasmic IgM expression in the context of the three currently recognised maturational stages of hematogones. Leuk Lymphoma (2009) 1.07

Principal component analysis of dietary and lifestyle patterns in relation to risk of subtypes of esophageal and gastric cancer. Ann Epidemiol (2011) 1.06

Two main genetic pathways lead to the transformation of chronic lymphocytic leukemia to Richter syndrome. Blood (2013) 1.06

Collagenous sprue is not always associated with dismal outcomes: a clinicopathological study of 19 patients. Mod Pathol (2009) 1.06

Mutations in a gene encoding a midbody kelch protein in familial and sporadic classical Hodgkin lymphoma lead to binucleated cells. Proc Natl Acad Sci U S A (2009) 1.05

Anemia in celiac disease is multifactorial in etiology. Am J Hematol (2007) 1.04

An update on celiac disease histopathology and the road ahead. Arch Pathol Lab Med (2012) 1.03

Chronic hepatitis C virus and celiac disease, is there an association? Dig Dis Sci (2007) 1.03

The frequent expression of cancer/testis antigens provides opportunities for immunotherapeutic targeting of sarcoma. Cancer Immun (2004) 1.02